Gavin Clark-Gartner

Yigal Nochomovitz

Alec Stranahan

Debjit Chattopadhyay

Ritu Baral

Andrea Newkirk

Samantha Corwin

Amit Corwin

Andrea Tan

Dae Gon Ha

Fiona Shang

Jiale Song

Joseph Pantginis

Josh Schimmer

Joshua Fleishman

Joshua Schimmer

Morgan Lamberti

Ry Forseth

Sami Corwin

- Krystal Biotech announced on **September 15, 2025**, that the **United States Food and Drug Administration (FDA) approved a label update for VYJUVEK®**.  **[1711279_26995ca8f97b4391aa5cd0bcdf392bec_0]** 
- The updated label **expands the eligible patient population to include dystrophic epidermolysis bullosa (DEB) patients from birth**.  **[1711279_26995ca8f97b4391aa5cd0bcdf392bec_0]** 
- This update also provides **patients and caregivers full flexibility to apply VYJUVEK themselves** and manage wound dressings without a 24-hour waiting period.  **[1711279_26995ca8f97b4391aa5cd0bcdf392bec_0]** 
- These changes are expected to **reinforce VYJUVEK’s leadership position** and improve patient compliance, solidifying it as the standard of care for DEB wounds.  **[1711279_26995ca8f97b4391aa5cd0bcdf392bec_0]**

Krystal Biotech Receives FDA Approval for Updated VYJUVEK® Label

Krystal Biotech (KRYS)